BMY

Bristol-Myers Squibb Co.
Data: 2026-07-27

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.

Quick Stats
Jul 27, 2026

53.1

AI Score

HOLD

0.87

Volume Ratio

Jul 30, 2026

Next Earnings

17

+ve Days (30d)

13

-ve Days (30d)

BMY Stock Summary

Last updated Jul 27, 2026

BMY is currently trading at $62.56, positioned above its 200-day moving average of $55.16, indicating a long-term uptrend. The stock has a 52-week range of $42.52 to $63.44.

Technical Analysis: The 50-day moving average stands at $57.57, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 65.152, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.007, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates BMY at 53.1/100 with a HOLD recommendation.

BMY (Bristol-Myers Squibb Co.) Indicators

Last updated Jul 27, 2026

Indicator Value
RSI(14) 65.152
CMF (20) 0.007
ROC (10) 5.426
ADX (14) 25.393
Indicator Value
MACD (12,26,9) 1.359
AROONOSC (14) 64.286
WILLAMS %R (14) -13.213
MFI (14) 70.335
BMY Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

BMY Price vs Max Options Open Interest
BMY Max Change In Options Open Interest

BMY Options - Sort by Max open Interest (near term)

27th July 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

BMY Daily Out of Money Options - Sort by Max open Interest (near term)

27th July 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

BMY Daily In the Money Options - Sort by Max open Interest (near term)

27th July 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

BMY Most Active Options by Volume(near term)

27th July 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

Bristol-Myers Squibb Co. is above both the 50 Day and 200 Day SMA which is considered Bullish.

BMY Moving Averages Analysis

Bristol-Myers Squibb Co. has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jul 27, 2026

Bristol-Myers Squibb Co. has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jul 27, 2026

BMY (Bristol-Myers Squibb Co.) Simple Moving Averages

Moving Averages are last updated Jul 27, 2026

Days MA
10 60.49
20 59.14
30 57.98
50 57.57
100 58.15
200 55.16

BMY Fundamental Analysis

P/E (Forward) 9.8425
P/E (Trailing) 17.3922
Market Cap ($) 126.8 billion
Earnings/Share ($) 3.57
Net Profit Margin (%) 0.1501
Dividend/Share ($) 2.5
EPS Estimate Current Year ($) 6.3434
EPS Estimate Next Year ($) 6.1966
WallStreet Target Price ($) 62.96
Most Recent Quarter